During the past decade, Paducah Retinal Center conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 21 clinical trials were completed, i.e. on average, 105% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 15 clinical trials were completed. i.e. 1500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Paducah Retinal Center" #1 sponsor was "Jaeb Center for Health Research" with 18 trials, followed by "Hoffmann-La Roche" with 8 trials sponsored, "Genentech, Inc." with 2 trials sponsored, "Alimera Sciences" with 1 trials sponsored and "Allergan" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Paducah Retinal Center" #1 collaborator was "National Eye Institute (NEI)" with 18 trials as a collaborator, "National Institutes of Health (NIH)" with 6 trials as a collaborator, "Genentech, Inc." with 4 trials as a collaborator, "Regeneron Pharmaceuticals" with 4 trials as a collaborator and "Allergan" with 3 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Paducah Retinal Center" are "Diabetic Macular Edema" (13 trials), "Diabetic Retinopathy" (6 trials), "Macular Degeneration" (4 trials), "Proliferative Diabetic Retinopathy" (4 trials) and "Geographic Atrophy" (3 trials). Many other conditions were trialed in "Paducah Retinal Center" in a lesser frequency.

Most popular intervention types in "Paducah Retinal Center" are "Drug" (29 trials), "Procedure" (8 trials), "Other" (6 trials), "Device" (5 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ranibizumab" (7 trials), "Faricimab" (3 trials), "Sham Procedure" (3 trials), "Deferred aflibercept" (2 trials) and "Deferred laser" (2 trials). Other intervention names were less common.

The vast majority of trials in "Paducah Retinal Center" are 36 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Paducah Retinal Center". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Paducah Retinal Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Paducah Retinal Center, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 24 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".